Cargando…

Potential for receptor-based antiviral drugs against SARS

Detalles Bibliográficos
Autores principales:	Williams, Richard K, Yeager, Curtis L, Holmes, Kathryn V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2003
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134702/ https://www.ncbi.nlm.nih.gov/pubmed/12853208 http://dx.doi.org/10.1016/S0140-6736(03)13818-4

Ejemplares similares

Rationale of receptor-based antivirals against SARS
Publicado: (2013)

Human aminopeptidase N is a receptor for human coronavirus 229E
por: Yeager, Curtis L., et al.
Publicado: (1992)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
por: Maurya, Vimal K., et al.
Publicado: (2020)

Potential antiviral effects of pantethine against SARS-CoV-2
por: Abou-Hamdan, M., et al.
Publicado: (2023)

Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
por: El-hoshoudy, A.N.
Publicado: (2020)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2
por: Pokhrel, Sushil, et al.
Publicado: (2021)

Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection
por: Maiti, Biplab K.
Publicado: (2020)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Potential Antiviral Options against SARS-CoV-2 Infection
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022)

Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2
por: Matyugina, E. S., et al.
Publicado: (2021)

Potential antiviral peptides against the nucleoprotein of SARS-CoV-2
por: Mahdi, Iktedar, et al.
Publicado: (2022)

Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection
por: Liu, Xiao-huan, et al.
Publicado: (2021)

Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach
por: Gangadharan, Sivakumar, et al.
Publicado: (2022)

Antioxidant Potential of Antiviral Drug Umifenovir
por: Proskurnina, Elena V., et al.
Publicado: (2020)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2
por: Jimenez-Guardeño, Jose M., et al.
Publicado: (2022)

Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method
por: Zhou, Liqian, et al.
Publicado: (2020)

The SARS Coronavirus receptor ACE 2 A potential target for antiviral therapy
por: Kuhn, Jens H., et al.
Publicado: (2006)

FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms
por: Ahmed, Mahmoud S., et al.
Publicado: (2023)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Glycyrrhizin: antiviral activity against SARS coronavirus
Publicado: (2013)

Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants
por: Cho, Junhyung, et al.
Publicado: (2023)

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
por: Park, Su-Jin, et al.
Publicado: (2020)

Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections
por: Osuna-Ramos, Juan Fidel, et al.
Publicado: (2023)

Antiviral Potential of Plants against Noroviruses
por: Sarowska, Jolanta, et al.
Publicado: (2021)

Identification of potential antivirals against SARS-CoV-2 using virtual screening method
por: Rahman, Mohammad Rejaur, et al.
Publicado: (2021)

Antiviral drugs against hepatitis C virus
por: Rehman, Sidra, et al.
Publicado: (2011)

Is Lipid Specificity Key to the Potential Antiviral Activity of Mouthwash Reagent Chlorhexidine against SARS-CoV-2?
por: Rathod, Arun K., et al.
Publicado: (2022)

Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction
por: Peng, Lihong, et al.
Publicado: (2020)

In vitro comparison of antiviral drugs against feline herpesvirus 1
por: van der Meulen, K, et al.
Publicado: (2006)

Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures
por: Peng, Lihong, et al.
Publicado: (2021)

Scoping insight on antiviral drugs against COVID-19
por: Ali, Ahmed S., et al.
Publicado: (2021)

Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches
por: Santos, Esley S., et al.
Publicado: (2022)

Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective
por: Abosheasha, Mohammed A., et al.
Publicado: (2021)

Sars-Cov-2 and risk of antiviral drug resistance
por: Vitiello, Antonio
Publicado: (2021)

Potential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2
por: Foka, Frank Eric Tatsing, et al.
Publicado: (2022)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hmeukk26oejnneopult019janr